CLINICAL RESPONSES TO GEFITINIB RETREATMENT IN NON-SMALL-CELL-LUNG-CANCER ADENOCARCINOMA PATIENTS WHO BENEFITED FROM PRIOR EFFECTIVE GEFITINIB THERAPY: A RETROSPECTIVE ANALYSIS

被引:0
作者
Li, Junling [1 ]
Yan, Wang [1 ]
Yuankai, Shi [1 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China
关键词
gefitinb; NSCLC; adenocarcinoma; readministration;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1291 / S1292
页数:2
相关论文
共 50 条
[41]   Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: A case report [J].
Yao, Yufeng ;
Zhu, Zhouyu ;
Wu, Yimin ;
Chai, Ying .
MEDICINE, 2018, 97 (18)
[42]   Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without Testing for Epidermal Growth Factor Receptor (EGFR) Mutations [J].
Wu, Jenn-Yu ;
Shih, Jin-Yuan ;
Chen, Kuan-Yu ;
Yang, Chih-Hsin ;
Yu, Chong-Jen ;
Yang, Pan-Chyr .
MEDICINE, 2011, 90 (03) :159-167
[43]   Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer [J].
Narita, Yusuke ;
Matsushima, Yukiko ;
Shiroiwa, Takeru ;
Chiba, Koji ;
Nakanishi, Yoichi ;
Kurokawa, Tatsuo ;
Urushihara, Hisashi .
LUNG CANCER, 2015, 90 (01) :71-77
[44]   Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer [J].
Song, Zhengbo ;
Yu, Xinmin ;
He, Chunxiao ;
Zhang, Beibei ;
Zhang, Yiping .
JOURNAL OF THORACIC DISEASE, 2013, 5 (04) :400-405
[45]   Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients [J].
Haringhuizen, A ;
van Tinteren, H ;
Vaessen, HFR ;
Baas, P ;
van Zandwijk, N .
ANNALS OF ONCOLOGY, 2004, 15 (05) :786-792
[46]   Comparing Gefitinib and Traditional Chemotherapy for Better Survival in Patients With Non-Small Cell Lung Cancer: A Systematic Review [J].
Kanagalingam, Suthasenthuran ;
Ul Haq, Zargham ;
Srinivasan, Nishok Victory ;
Khan, Aujala Irfan ;
Mashat, Ghadi D. ;
Hazique, Mohammad ;
Khan, Kokab Irfan ;
Ramesh, Prasana ;
Khan, Safeera .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[47]   Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations [J].
Yoon, Shinkyo ;
Lee, Dae Ho ;
Kim, Sang-We .
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (01)
[48]   Complete Metabolic Remission with Gefitinib in a Hemodialysis Patient with Bone Metastases from Non-small Cell Lung Cancer [J].
Del Conte, Alessandro ;
Minatel, Emilio ;
Schinella, Domenico ;
Baresic, Tanja ;
Basso, Stefano M. M. ;
Lumachi, Franco .
ANTICANCER RESEARCH, 2014, 34 (1A) :319-322
[49]   Gefitinib for asymptomatic brain metastasis from advanced non-small cell lung cancer: Report of a favourable outcome [J].
Liu, Wen-Yang ;
Liu, Yu-Tao ;
Yang, Lin ;
Zhang, Ye ;
Liu, Peng ;
Wang, Yan ;
Hui, Zhou-Guang .
THORACIC CANCER, 2016, 7 (04) :498-502
[50]   Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection [J].
Hata, Akito ;
Katakami, Nobuyuki ;
Yoshioka, Hiroshige ;
Fujita, Shiro ;
Kunimasa, Kei ;
Nanjo, Shigeki ;
Otsuka, Kyoko ;
Kaji, Reiko ;
Tomii, Keisuke ;
Iwasaku, Masahiro ;
Nishiyama, Akihiro ;
Hayashi, Hidetoshi ;
Morita, Satoshi ;
Ishida, Tadashi .
LUNG CANCER, 2011, 74 (02) :268-273